The chief executive of the Chinese giant that owns the Swisse vitamins group expects daigou traders will remain on the sidelines for the next few months.
The Swisse business suffered a 36 per cent slump in sales revenue to $127 million in Australia and New Zealand in the six months ended June 30.
Loading...
Simon Evans writes on business specialising in retail, manufacturing, beverages, mining and M&A. He is based in Adelaide. Connect with Simon on Twitter. Email Simon at simon.evans@afr.com
